LENVIMA vs THYRO-TABS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. LENVIMA and THYRO-TABS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	LENVIMA	THYRO-TABS
Rating	New	70/100
Pharmacy pays	—	~$1.83 /30
Type	RX	RX
Active ingredient	LENVATINIB MESYLATE	LEVOTHYROXINE SODIUM
Manufacturer	Eisai Inc	Alvogen
Dosage forms	Capsule, Kit	Tablet
Drug class	—	L-Thyroxine
Boxed warning	None	Boxed warning
Half-life	—	about 6 to 7 days in adults with normal thyroid function
Treats	Renal Cell Carcinoma, Thyroid Neoplasms	Goiter, Myxedema, Thyroid Neoplasms

lenvima thyro-tabs

Rating

New

70/100

Pharmacy pays

—

~$1.83 /30

Type

Active ingredient

LENVATINIB MESYLATE

LEVOTHYROXINE SODIUM

Manufacturer

Eisai Inc

Alvogen

Dosage forms

Capsule, Kit

Tablet

Drug class

—

L-Thyroxine

Boxed warning

None

Boxed warning

Half-life

—

about 6 to 7 days in adults with normal thyroid function

Treats

Renal Cell Carcinoma, Thyroid Neoplasms

Goiter, Myxedema, Thyroid Neoplasms

Frequently asked questions

What is the difference between Lenvima and Thyro-Tabs?

Lenvima contains Lenvatinib Mesylate, while Thyro-Tabs contains Levothyroxine Sodium — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.